Beurs gesloten -
BME
17:35:26 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
28,96
EUR
|
+0,49%
|
|
+10,37%
|
-29,50%
|
Fiscaal tijdperk: März |
2020
|
2021
|
2022
|
2023
|
2025
|
2026
|
2027
|
---|
Marktkapitalisatie
1 |
966,8
|
1.792
|
1.232
|
800,7
|
510,8
|
-
|
-
|
Bedrijfswaarde
1 |
828
|
1.625
|
1.039
|
672
|
327,2
|
233,3
|
510,8
|
K/w-verhouding
|
6,98
x
|
19,3
x
|
25,1
x
|
737
x
|
11,3
x
|
5,85
x
|
3,92
x
|
Dividendrendement
|
1,15%
|
0,66%
|
-
|
-
|
1,7%
|
2,27%
|
-
|
Marktkapitalisatie/omzet
|
3,58
x
|
7,8
x
|
6,28
x
|
5,06
x
|
2,61
x
|
2,14
x
|
2,26
x
|
Bedrijfswaarde/omzet
|
3,07
x
|
7,07
x
|
5,29
x
|
4,25
x
|
1,67
x
|
0,98
x
|
2,26
x
|
Bedrijfswaarde/EBITDA
|
5,07
x
|
16,6
x
|
20,8
x
|
322
x
|
3,78
x
|
1,78
x
|
14,2
x
|
Bedrijfswaarde/FCF
|
3
x
|
90,9
x
|
35,3
x
|
-22,9
x
|
4,9
x
|
2,34
x
|
-
|
FCF Yield
|
33,3%
|
1,1%
|
2,83%
|
-4,38%
|
20,4%
|
42,7%
|
-
|
Price to Book
|
-
|
10
x
|
5,56
x
|
4,03
x
|
2,18
x
|
1,79
x
|
-
|
Aantal aandelen (in duizenden)
|
18.496
|
18.113
|
18.011
|
18.108
|
17.640
|
-
|
-
|
Referentieprijs
2 |
52,27
|
98,95
|
68,42
|
44,22
|
28,96
|
28,96
|
28,96
|
Datum van publicatie
|
26/02/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: März |
2020
|
2021
|
2022
|
2023
|
2025
|
2026
|
2027
|
---|
Omzet
1 |
270
|
229,8
|
196,3
|
158,2
|
195,9
|
238,5
|
225,8
|
EBITDA
1 |
163,2
|
98,03
|
49,97
|
2,084
|
86,67
|
131,3
|
36
|
Bedrijfsresultaat (EBIT)
1 |
155,9
|
92,45
|
44,07
|
-3,827
|
63,62
|
102,1
|
99,8
|
Operationele Marge
|
57,77%
|
40,22%
|
22,45%
|
-2,42%
|
32,48%
|
42,81%
|
44,2%
|
Resultaat voor belastingen (EBT)
1 |
145,6
|
95,13
|
43,79
|
-3,623
|
35,85
|
76,8
|
101,4
|
Nettowinst (verlies)
1 |
137,3
|
92,86
|
49,36
|
1,137
|
56,88
|
91,72
|
109,4
|
Nettomarge
|
50,85%
|
40,4%
|
25,14%
|
0,72%
|
29,03%
|
38,46%
|
48,43%
|
WPA
2 |
7,490
|
5,130
|
2,730
|
0,0600
|
2,572
|
4,952
|
7,380
|
Free Cash Flow
1 |
275,9
|
17,87
|
29,47
|
-29,4
|
66,8
|
99,75
|
-
|
FCF-marge
|
102,21%
|
7,78%
|
15,01%
|
-18,59%
|
34,1%
|
41,83%
|
-
|
Kasstroomconversie (ebitda)
|
169,13%
|
18,23%
|
58,97%
|
-
|
77,08%
|
75,95%
|
-
|
Kasstroomconversie (nettowinst)
|
201,03%
|
19,25%
|
59,71%
|
-
|
117,45%
|
108,75%
|
-
|
Dividend per aandeel
2 |
0,6000
|
0,6500
|
-
|
-
|
0,4925
|
0,6567
|
-
|
Datum van publicatie
|
26/02/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: März |
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
98,69
|
45,25
|
85,89
|
34,94
|
30,19
|
65,13
|
18,71
|
54,94
|
33,98
|
46,21
|
80,19
|
37,45
|
40,51
|
33,33
|
44,6
|
38
|
36,3
|
EBITDA
1 |
40,57
|
12,49
|
44,82
|
20,6
|
11,31
|
31,94
|
12,56
|
5,436
|
-1,258
|
5,418
|
4,16
|
1,309
|
-3,385
|
-3,3
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
37,95
|
-
|
43,36
|
19,01
|
9,829
|
28,84
|
11,86
|
3,372
|
-2,572
|
4,047
|
1,475
|
-0,184
|
-5,118
|
-3,467
|
0,3
|
-2
|
-8,6
|
Operationele Marge
|
38,45%
|
-
|
50,48%
|
54,42%
|
32,55%
|
44,28%
|
63,38%
|
6,14%
|
-7,57%
|
8,76%
|
1,84%
|
-0,49%
|
-12,63%
|
-10,4%
|
0,67%
|
-5,26%
|
-23,69%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-
|
-
|
-
|
11,99
|
32,61
|
14
|
-2,821
|
-3,217
|
4,497
|
-
|
1,57
|
-6,473
|
-1,1
|
0,3
|
-2
|
-8,4
|
Nettowinst (verlies)
1 |
43,2
|
11,5
|
38,16
|
22
|
12,95
|
34,92
|
8,477
|
5,984
|
1,411
|
5,024
|
6,435
|
1,521
|
-6,819
|
-3,233
|
0,4
|
-2,3
|
-9,5
|
Nettomarge
|
43,78%
|
25,41%
|
44,43%
|
62,97%
|
42,88%
|
53,62%
|
45,32%
|
10,89%
|
4,15%
|
10,87%
|
8,02%
|
4,06%
|
-16,83%
|
-9,7%
|
0,9%
|
-6,05%
|
-26,17%
|
WPA
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0,0700
|
0,0200
|
-0,1100
|
-0,4500
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/07/21
|
28/10/21
|
28/02/22
|
28/04/22
|
27/07/22
|
27/07/22
|
27/10/22
|
28/02/23
|
26/04/23
|
27/07/23
|
27/07/23
|
26/10/23
|
28/02/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: März |
2020
|
2021
|
2022
|
2023
|
2025
|
2026
|
2027
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
139
|
167
|
193
|
129
|
184
|
278
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
276
|
17,9
|
29,5
|
-29,4
|
66,8
|
99,8
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
241%
|
66,2%
|
24,6%
|
0,55%
|
28,9%
|
31,6%
|
-
|
ROA (netto-inkomsten/totale activa)
|
60,3%
|
26,6%
|
13%
|
-
|
15,5%
|
23,4%
|
-
|
Totale activa
1 |
227,5
|
349,3
|
380,8
|
-
|
366,9
|
392
|
-
|
Nettoactief per aandeel
2 |
-
|
9,850
|
12,30
|
11,00
|
13,30
|
16,20
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
3
|
7,8
|
8,85
|
16
|
9,4
|
10,5
|
16
|
Capex/omzet
|
1,11%
|
3,4%
|
4,51%
|
10,09%
|
4,8%
|
4,4%
|
7,09%
|
Datum van publicatie
|
26/02/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
28,96
EUR Gemiddelde koersdoel
49,2
EUR Spread / Gemiddelde doel +69,89% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -29,50% | 545 mln. | | -4,66% | 86,13 mld. | | +1,32% | 39,82 mld. | | -19,27% | 30,42 mld. | | +57,86% | 25,23 mld. | | -16,09% | 15,35 mld. | | -9,14% | 11,95 mld. | | -17,69% | 11,6 mld. | | -43,00% | 11,51 mld. | | +5,24% | 8,71 mld. |
Biofarmaceutica
|